147 related articles for article (PubMed ID: 12687504)
41. ANCA seropositivity in HIV: a serological pitfall.
Jansen TL; van Houte D; de Vries T; Wolthuis A
Neth J Med; 2005; 63(7):270-4. PubMed ID: 16093579
[TBL] [Abstract][Full Text] [Related]
42. Laboratory diagnostics in vasculitis patients.
Wiik A
Isr Med Assoc J; 2001 Apr; 3(4):275-7. PubMed ID: 11344841
[TBL] [Abstract][Full Text] [Related]
43. ANCA-associated vasculitis with renal involvement: an outcome analysis.
Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
[TBL] [Abstract][Full Text] [Related]
44. Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis.
Mulder L; van Rossum M; Horst G; Limburg P; de Graeff-Meeder ER; Kuis W; Kallenberg C
J Rheumatol; 1997 Mar; 24(3):568-75. PubMed ID: 9058667
[TBL] [Abstract][Full Text] [Related]
45. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of anti-neutrophil cytoplasmic antibodies in patients with chronic hepatitis C infection associated mixed cryoglobulinemia.
Cojocaru M; Cojocaru IM; Iacob SA
Rom J Intern Med; 2006; 44(4):427-31. PubMed ID: 18386619
[TBL] [Abstract][Full Text] [Related]
47. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD).
Trevisin M; Pollock W; Dimech W; Savige J
J Immunol Methods; 2008 Jul; 336(2):104-12. PubMed ID: 18499121
[TBL] [Abstract][Full Text] [Related]
49. [Anti-neutrophil cytoplasmic antibody--enzyme immunosorbent assay].
Arimura Y; Marumo T; Fujii A; Nakabayashi K; Nagasawa T
Rinsho Byori; 2001 Jun; 49(6):571-4. PubMed ID: 11452543
[TBL] [Abstract][Full Text] [Related]
50. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
Wieczorek S; Hellmich B; Arning L; Moosig F; Lamprecht P; Gross WL; Epplen JT
Arthritis Rheum; 2008 Jun; 58(6):1839-48. PubMed ID: 18512809
[TBL] [Abstract][Full Text] [Related]
51. Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease).
Halacheva KS; Manolova IM; Petkov DP; Andreev AP
Scand J Immunol; 1998 Nov; 48(5):544-50. PubMed ID: 9822265
[TBL] [Abstract][Full Text] [Related]
52. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
53. [Antineutrophil cytoplasmic antibodies in 2 patients with Wegener's granulomatosis].
Larraga R; Manero FJ; Bell S; Herrero Y; Chacón E; Hernández A
An Med Interna; 1998 Oct; 15(10):538-40. PubMed ID: 9844230
[TBL] [Abstract][Full Text] [Related]
54. Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive lesions.
Peikert T; Finkielman JD; Hummel AM; McKenney ME; Gregorini G; Trimarchi M; Specks U
Arthritis Rheum; 2008 May; 58(5):1546-51. PubMed ID: 18438818
[TBL] [Abstract][Full Text] [Related]
55. The antineutrophil cytoplasmic antibody-associated vasculitides.
Seo P; Stone JH
Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
[TBL] [Abstract][Full Text] [Related]
56. [Clinical study on five myeloperoxidase specific anti-neutrophil cytoplasmic antibody (MPO-ANCA) positive Churg-Strauss syndrome cases].
Yoshihara K; Arimura Y; Kobayashi O; Minoshima S; Kobayashi M; Yomogita S; Soejima A; Nakabayashi K; Kitamoto K; Nagasawa T
Ryumachi; 1998 Oct; 38(5):696-704. PubMed ID: 9852746
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
58. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
Pradhan VD; Badakere SS; Bichile LS; Almeida AF
J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
[TBL] [Abstract][Full Text] [Related]
59. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
60. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
